RESUMO
The use of 5-methylcytosine demethylating agents in conjunction with inhibitors of histone deacetylation may offer a new therapeutic strategy for lung cancer. Monitoring the efficacy of gene demethylating treatment directly within the tumour may be difficult due to tumour location. This study determined the positive and negative predictive values of sputum and serum for detecting gene methylation in primary lung cancer. A panel of eight genes was evaluated by comparing methylation detected in the primary tumour biopsy to serum and sputum obtained from 72 patients with Stage III lung cancer. The prevalence for methylation of the eight genes in sputum (21-43%) approximated to that seen in tumours, but was 0.7-4.3-fold greater than detected in serum. Sputum was superior to serum in classifying the methylation status of genes in the tumour biopsy. The positive predictive value of the top four genes (p16, DAPK, PAX5 beta, and GATA5) was 44-72% with a negative predictive value for these genes > or =70%. The highest specificity was seen for the p16 gene, and this was associated with a odds ratio of six for methylation in the tumour when this gene was methylated in sputum. In contrast, for serum, the individual sensitivity for all genes was 6-27%. Evaluating the combined effect of methylation of at least one of the four most significant genes in sputum increased the positive predictive value to 86%. These studies demonstrate that sputum can be used effectively as a surrogate for tumour tissue to predict the methylation status of advanced lung cancer where biopsy is not feasible.
Assuntos
Carcinoma Pulmonar de Células não Pequenas/genética , Metilação de DNA , Neoplasias Pulmonares/genética , Regiões Promotoras Genéticas , Escarro/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Pulmonar de Células não Pequenas/sangue , Feminino , Humanos , Neoplasias Pulmonares/sangue , Masculino , Pessoa de Meia-Idade , Escarro/citologiaRESUMO
Intravenous vitamin D is standard therapy for secondary hyperparathyroidism in hemodialysis (HD) patients. In for-profit dialysis clinics, mortality was higher for patients on calcitriol compared to paricalcitol. Doxercalciferol, a second vitamin D2 analog, is currently available. We assessed mortality associated with each vitamin D analog and with lack of vitamin D therapy in patients who began HD at Dialysis Clinic Inc. (DCI), a not-for-profit dialysis provider. During the 1999-2004 study period we studied 7731 patients (calcitriol: n=3212; paricalcitol: n=2087; doxercalciferol: n=2432). Median follow-up was 37 weeks. Mortality rates (deaths/100 patient-years) were identical in patients on doxercalciferol (15.4, 95% confidence interval (13.6-17.1)) and paricalcitol (15.3 (13.6-16.9)) and higher in patients on calcitriol (19.6 (18.2-21.1)) (P<0.0001). In all models mortality was similar for paricalcitol versus doxercalciferol (hazard ratios=1.0). In unadjusted models, mortality was lower in patients on doxercalciferol (0.80 (0.66, 0.96)) and paricalcitol (0.79 (0.68, 0.92)) versus calcitriol (P<0.05). In adjusted models, this difference was not statistically significant. In all models mortality was higher for patients who did not receive vitamin D versus those who did (1.2 (1.1-1.3)). Mortality in doxercalciferol- and paricalcitol-treated patients was virtually identical. Differences in survival between vitamin D2 and D3 may be smaller than previously reported.
Assuntos
Conservadores da Densidade Óssea/uso terapêutico , Calcitriol/uso terapêutico , Ergocalciferóis/uso terapêutico , Hiperparatireoidismo Secundário/tratamento farmacológico , Diálise Renal/mortalidade , Vitamina D/análogos & derivados , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças Ósseas Metabólicas/sangue , Cálcio/sangue , Feminino , Humanos , Hiperparatireoidismo Secundário/mortalidade , Falência Renal Crônica/complicações , Falência Renal Crônica/terapia , Masculino , Pessoa de Meia-Idade , Hormônio Paratireóideo/sangue , Fósforo/sangue , Diálise Renal/efeitos adversos , Estudos Retrospectivos , Fatores de Risco , Análise de SobrevidaRESUMO
BACKGROUND: In spite of the effectiveness of mammography screening for early detection of breast carcinoma, the use of screening mammography varies widely across racial and ethnic groups. Recently, concerns have been raised about the potential adverse effect a benign breast biopsy may have on subsequent mammography utilization, including subsequent use among minority women. METHODS: Computerized health care claims data for 1991 through 1997 from a managed care organization were used to compare mammography use among Hispanic and non-Hispanic women who had had a mammogram followed by an incisional or excisional benign breast biopsy to women who had had a mammogram and no biopsy. Through survival analysis methods, the time-to-next mammogram was compared among these three groups. RESULTS: The sample included 693 (3.2%) and 289 (1.3%) women who had had a mammogram followed by an incisional biopsy or an excisional biopsy, respectively, and 20,540 (95.4%) women who had had a mammogram and no biopsy. Both Hispanic and non-Hispanic women with a biopsy returned sooner for subsequent mammograms than women without a biopsy (P < 0.0001). Hispanic women without a biopsy returned later than non-Hispanic women without a biopsy (P < 0.0001). However, Hispanic women with an excisional biopsy returned sooner than non-Hispanic women (P < 0.05). CONCLUSIONS: Within a managed care organization, both Hispanic and non-Hispanic women who had had a mammogram followed by a benign breast biopsy returned sooner for a subsequent mammogram than women who had had a mammogram and no biopsy. However, ethnic differences in time-to-next mammogram were observed for women without a biopsy and those with an excisional biopsy. Hispanic women without a biopsy returned later for a subsequent mammogram than non-Hispanic women in similar groups, but those with an excisional biopsy returned sooner.
Assuntos
Neoplasias da Mama/patologia , Adulto , Distribuição por Idade , Idoso , Biópsia , Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/etnologia , Feminino , Hispânico ou Latino , Humanos , Mamografia , Programas de Rastreamento , Pessoa de Meia-Idade , Modelos EstatísticosRESUMO
The differences in costs for health care services between women with breast cancer and those without were estimated for Hispanic and non-Hispanic members of a managed care organization. A total of 317 cases of breast cancer and 949 controls were selected using a comprehensive patient database. All health care costs for the 4-12 months prior to the case's diagnosis and for the 12 months following the case's diagnosis were obtained. Costs were defined as charges to the health plan. Mean differences in total health care costs between cases and controls were predicted using Tobit models for 4-12 months prior to diagnosis and the year after diagnosis by age group. Compared to controls, women diagnosed with in situ breast cancers in all age groups had significantly higher health care costs 4-12 months prior to diagnosis. For women under 50 years of age, the difference in costs for cases compared to controls 12 months after diagnosis was almost three times greater for women with regional/distant disease ($17,093 +/- $1,559) compared to in situ disease ($5,089 +/- $1,050). For women in the two other age groups (50-70 years and over 70 years), the difference was over twice as great for those with regional/distant disease compared to those with in situ disease. Mean differences between cases and controls in health care costs 12 months after diagnosis were similar for Hispanic and non-Hispanic women for all stages of disease.
Assuntos
Neoplasias da Mama/economia , Neoplasias da Mama/etnologia , Efeitos Psicossociais da Doença , Custos de Cuidados de Saúde , Hispânico ou Latino/estatística & dados numéricos , Programas de Assistência Gerenciada/economia , Adulto , Idoso , Neoplasias da Mama/patologia , Neoplasias da Mama/terapia , Estudos de Casos e Controles , Feminino , Humanos , Pessoa de Meia-Idade , New Mexico , Análise de RegressãoRESUMO
Reduced DNA repair capacity of carcinogen-induced DNA damage is now thought to significantly influence inherent susceptibility to lung cancer. DNA-dependent protein kinase (DNA-PK) is a serine-threonine kinase activated by the presence of double-strand breaks in DNA that appears to play a major role in non-homologous recombination and transcriptional control. The purpose of this study was to determine whether DNA-PK activity varies among individuals and how this affects lung cancer risk. DNA-PK activity in peripheral mononuclear cells from individuals with lung cancer (n = 41) was compared with lung cancer-free controls (n = 41). Interindividual variability was seen within each group, however, significant differences (P = 0.03) in DNA-PK activity between cases and controls were seen when comparing the distribution of enzyme activity among these two groups. The percentages of cases and controls with DNA-PK activity in the ranges 2.5-5.0 and 7.6-10.0 units were 39 versus 20% and 7 versus 29%, respectively. The enzyme activity in peripheral mononuclear cells reflected that seen in bronchial epithelial cells, one progenitor cell for lung cancer, supporting the use of peripheral mononuclear cells for larger population-based studies of DNA-PK activity. Its role as a potential modifier for lung cancer risk was supported by the fact that cell growth in bronchial epithelial cells exposed to bleomycin was directly associated with enzyme activity. The results of this study demonstrate that reduced DNA-PK repair activity is associated with risk for lung cancer.
Assuntos
Proteínas de Ligação a DNA , Neoplasias Pulmonares/enzimologia , Proteínas Serina-Treonina Quinases/metabolismo , Adulto , Idoso , Bleomicina/farmacologia , Estudos de Casos e Controles , Sobrevivência Celular/efeitos dos fármacos , Proteína Quinase Ativada por DNA , Feminino , Humanos , Neoplasias Pulmonares/patologia , Masculino , Pessoa de Meia-Idade , Proteínas NuclearesRESUMO
Defects in the repair and maintenance of DNA increase risk for cancer. X-ray cross-complementing group 1 protein (XRCC1) is involved with the repair of DNA single-strand breaks. A nucleotide substitution of guanine to adenine leading to a non-conservative amino acid change was identified in the XRCC1 gene at codon 399 (Arg/Gln). This change is associated with higher levels of aflatoxin B1-adducts and glycophorin A somatic mutations. A case-control study was conducted to test the hypothesis that the 399Gln allele is positively associated with risk for adenocarcinoma of the lung. XRCC1 genotypes were assessed at codon 399 in 172 cases of lung adenocarcinoma and 143 cancer-free controls. Two ethnic populations were represented, non-Hispanic White and Hispanic. The distribution of XRCC1 genotypes differed between cases and controls. Among cases, 47.7% were Arg/Arg, 35.5% were Arg/Gln, and 16.9% were Gln/Gln. Among controls, XRCC1 allele frequencies were 45.5% for Arg/Arg, 44.8% for Arg/Gln, and 9.8% for Gln/Gln. Logistic regression analysis was used to assess the association between lung adenocarcinoma and the G/G genotype relative to the A/A or A/G genotypes. In non-Hispanic White participants, the lung cancer risk associated with the G/G genotype increased significantly after adjustment for age (OR=2.81; 95% CI, 1.2-7.9; P=0.03) and increased further after adjustment for smoking (OR=3.25; 95% CI, 1.2-10.7; P=0.03). Among all groups, a significant association was found between the G/G homozygote and lung cancer (OR=2.45; 95% CI, 1.1-5.8; P=0.03) after adjustment for age, ethnicity, and smoking. This study links a functional polymorphism in the critical repair gene XRCC1 to risk for adenocarcinoma of the lung.
Assuntos
Adenocarcinoma/genética , Proteínas de Ligação a DNA/genética , Neoplasias Pulmonares/genética , Adenocarcinoma/etnologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Alelos , Frequência do Gene , Marcadores Genéticos/genética , Predisposição Genética para Doença , Glutamina/genética , Humanos , Neoplasias Pulmonares/etnologia , Pessoa de Meia-Idade , Fatores de Risco , Proteína 1 Complementadora Cruzada de Reparo de Raio-XRESUMO
Occupational exposures were investigated in a multicenter case-control study of clinically and histologically diagnosed idiopathic pulmonary fibrosis (IPF), a chronic diffuse interstitial lung disease of unknown etiology. Results are based on 248 cases, aged 20-75 years, diagnosed at 16 referral centers between January 1989 and July 1993. There were 491 controls ascertained by random digit dialing and matched to cases on sex, age, and geographic region. Data were collected using a standard telephone questionnaire. Occupational factors were based on a detailed history of jobs lasting 6 months or more and job activity, hobby, and specific substance checklists. Several occupational factors, adjusted for age and smoking in conditional multivariate logistic regression analyses, were significantly associated with IPF: farming (odds ratio (OR) = 1.6, 95% confidence interval (CI): 1.0, 2.5); livestock (OR = 2.7, 95% CI: 1.3, 5.5); hairdressing (OR = 4.4, 95% CI: 1.2, 16.3); metal dust (OR = 2.0, 95% CI: 1.0, 4.0); raising birds (OR = 4.7, 95% CI: 1.6, 14.1); stone cutting/polishing (OR = 3.9, 95% CI: 1.2, 12.7); and vegetable dust/animal dust (OR = 4.7, 95% CI: 2.1, 10.4). Interaction was detected between smoking and exposure to livestock (p = 0.06) and farming (p = 0.08). Results confirm previous studies showing increased risk associated with dusty environments.
Assuntos
Exposição Ambiental , Exposição Ocupacional , Fibrose Pulmonar/etiologia , Adulto , Idoso , Agricultura , Estudos de Casos e Controles , Poeira , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Ocupações , Medição de Risco , Fumar/efeitos adversosRESUMO
Proton magnetic resonance spectroscopy (1H-MRS) offers a unique insight into brain cellular metabolism following traumatic brain injury (TBI). The aim of the present study was to assess change in neurometabolite markers of brain injury during the recovery period following TBI. We studied 19 TBI patients at 1.5, 3, and 6 months postinjury and 28 controls. We used 1H-MRS to quantify N-acetylaspartate (NAA), creatine (Cre), choline (Cho), and myoinositol (mIns) in occipitoparietal gray matter (GM) and white matter (WM) remote from the primary injury focus. Neuropsychological testing quantified cognitive impairment and recovery. At 1.5 months, we found cognitive impairment (mean z score = -1.36 vs. 0.18,p < 0.01), lower NAA (GM: 12.42 mM vs. 13.03, p = 0.01; WM: 11.75 vs. 12.81, p < 0.01), and elevated Cho (GM: 1.51 vs. 1.25, p < 0.01; WM: 1.98 vs. 1.79, p < 0.01) in TBI patients compared with controls. GM NAA at 1.5 months predicted cognitive function at outcome (6 months postinjury; r = 0.63, p = 0.04). GM NAA continued to fall by 0.46 mM between 1.5 and 3 months (p = 0.02) indicating continuing neuronal loss, metabolic dysfunction, or both. Between 3 and 6 months, WM NAA increased by 0.55 mM (p = 0.06) suggesting metabolic recovery. Patients with poorer outcomes had elevated mean GM Cho at 3 months postinjury, suggesting active inflammation, as compared to patients with better outcomes (p = 0.002). 1H-MRS offers a noninvasive approach to assessing neuronal injury and inflammation following TBI, and may provide unique data for patient management and assessment of therapeutic efficacy.
Assuntos
Ácido Aspártico/análogos & derivados , Lesões Encefálicas/metabolismo , Colina/metabolismo , Transtornos Cognitivos/diagnóstico , Creatinina/metabolismo , Inositol/metabolismo , Adolescente , Adulto , Idoso , Ácido Aspártico/metabolismo , Lesões Encefálicas/complicações , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/metabolismo , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Espectroscopia de Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Prótons , Estatísticas não ParamétricasRESUMO
The current study sought to investigate the reproducibility of a quantitative spectroscopic examination, using rigorous positioning guidelines and automated spectral fitting for measuring the cerebral metabolites N-acetylaspartate (NAA), creatine (Cre), choline (Cho), and myo-inositol (ml). Ten subjects were studied in three sessions to determine the variability associated with measurement of metabolites in normal-appearing occipitoparietal white matter, using short echo STEAM spectroscopy. A careful relocalization protocol based on local landmarks identified on thin-slice images was used. No changes in mean metabolite concentrations for each subject between sessions were found, confirming relocalization. Mean coefficients of variation in measurement of NAA, Cre, Cho, and ml were 3.30, 4.33, 5.30, and 8.10, respectively. These data suggest that changes in metabolite concentrations as small as 12% can be confidently discerned in an individual subject over time. The implication of these results to study design is discussed.
Assuntos
Ácido Aspártico/análogos & derivados , Encéfalo/metabolismo , Colina/metabolismo , Creatina/metabolismo , Inositol/metabolismo , Espectroscopia de Ressonância Magnética , Adulto , Ácido Aspártico/metabolismo , Feminino , Seguimentos , Humanos , Masculino , Prótons , Reprodutibilidade dos TestesRESUMO
BACKGROUND AND PURPOSE: To determine the neurometabolic patterns of brain injury in systemic lupus erythematosus with antiphospholipid antibody syndrome (SLE-aPLS). METHODS: Forty-nine SLE patients (12 SLE-aPLS) and 23 control subjects were studied using magnetic resonance imaging and spectroscopy. N-Acetylaspartate/creatine (NAA/Cre) and choline/Cre (Cho/Cre) were measured in normal-appearing tissue. IgG and IgM antiphospholipid antibodies (aPL) were measured by enzyme-linked immunosorbent assay. RESULTS: Stroke, epilepsy, and elevated IgG-aPL were more common in SLE-aPLS patients than in SLE patients (P<0.001). NAA/Cre was lower (P<0.05) and Cho/Cre higher (P<0.001) in SLE-aPLS patients than in SLE patients without aPLS. Regression models showed NAA/Cre was most related to injury seen by imaging (P<0.01), disease duration (P<0. 05), and prior neuropsychiatric SLE (NPSLE) (P=0.07). Reduced NAA/Cre was more closely related to IgG-aPL (P<0.01) than the presence of stroke or aPLS. When adjusted for all factors, Cho/Cre was most associated with the presence of aPLS (P=0.05). CONCLUSIONS: SLE and SLE-aPLS are actually a clinical continuum describing brain injury in SLE, with SLE-aPLS being characterized by increased aPL, NPSLE, stroke, epilepsy, and disturbed neurochemistry. An elevated IgG-aPL level is a potent risk factor for brain injury as measured by NAA/Cre in SLE that is independent of stroke and aPLS. However, thrombotic phenomena and the presence of aPL (aPLS) are most closely associated with increased Cho/Cre in SLE. These results suggest that aPLs exacerbate SLE, resulting in increased thrombotic and nonthrombotic brain injuries. Spectroscopy detects brain injury in SLE and may permit better understanding of the neurological consequences of SLE and SLE-aPLS.
Assuntos
Síndrome Antifosfolipídica/metabolismo , Ácido Aspártico/análogos & derivados , Encefalopatias/metabolismo , Lúpus Eritematoso Sistêmico/metabolismo , Adulto , Síndrome Antifosfolipídica/complicações , Síndrome Antifosfolipídica/imunologia , Ácido Aspártico/análise , Ácido Aspártico/metabolismo , Biomarcadores , Química Encefálica/imunologia , Encefalopatias/diagnóstico , Encefalopatias/etiologia , Infarto Cerebral/etiologia , Infarto Cerebral/metabolismo , Feminino , Humanos , Modelos Lineares , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/imunologia , Imageamento por Ressonância Magnética , Espectroscopia de Ressonância Magnética , Masculino , Pessoa de Meia-Idade , PrótonsRESUMO
PURPOSE: To investigate with statistical analysis the relationship between brain injury measured with magnetic resonance (MR) imaging and that measured with proton (hydrogen-1) MR spectroscopy. MATERIALS AND METHODS: Forty-two patients (34 female, eight male; mean age +/- SD, 38.7 years +/- 13.1; age range, 6-60 years) with systemic lupus erythematosus (SLE) were examined with H-1 MR spectroscopy to measure N-acetylaspartate (NAA), creatine (Cr), and choline (Cho) levels in normal-appearing white matter and with MR imaging to detect anatomic abnormalities. RESULTS: Results of linear regression analysis revealed an association between the NAA/Cr ratio and anatomic abnormalities (P = .03). However, only small focal lesions were independently related to NAA/Cr ratio changes (P = .04). Results of a similar analysis showed associations between the Cho/Cr ratio and anatomic abnormalities (P = .002). An elevated Cho/Cr ratio and cerebral infarction were independently associated (P = .02), as were a decreased Cho/Cr ratio and severe cortical atrophy (P = .02). CONCLUSION: Cerebrovascular abnormalities underlie diffuse cerebral injury in SLE, with small vessel injury (i.e., small focal lesions) primarily associated with a decreased NAA/Cr ratio and medium vessel injury (i.e., infarct) primarily associated with an increased Cho/Cr ratio. Statistical integration of H-1 MR spectroscopic and MR imaging findings over large data sets provides insights into the relevance of individual MR imaging-visible brain abnormalities in SLE. This statistical approach may be applicable to other systemic diseases complicated by brain injury.
Assuntos
Doenças Autoimunes/metabolismo , Encefalopatias/metabolismo , Encéfalo/metabolismo , Lúpus Eritematoso Sistêmico/metabolismo , Adolescente , Adulto , Doenças Autoimunes/diagnóstico , Encéfalo/patologia , Química Encefálica , Encefalopatias/diagnóstico , Criança , Feminino , Análise de Fourier , Humanos , Modelos Lineares , Lúpus Eritematoso Sistêmico/diagnóstico , Imageamento por Ressonância Magnética/instrumentação , Imageamento por Ressonância Magnética/métodos , Imageamento por Ressonância Magnética/estatística & dados numéricos , Espectroscopia de Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Estatísticas não ParamétricasRESUMO
OBJECTIVE: To study the association of perinatal human immunodeficiency virus (HIV)-1 transmission with birth outcomes, including birth weight, gestational age, ponderal index, head circumference, and weight/head ratio. METHODS: Data from a prospective cohort study of 627 pregnant women and their infants in Butare, Rwanda, from October 1989 until April 1994 were analyzed. A total of 318 HIV-1-infected and 309 seronegative women were enrolled during pregnancy and gave birth to 590 live singletons. Multiple linear regression modeling was used to assess the association of mother-child HIV status with several birth outcome measures. RESULTS: Unadjusted mean birth weight of HIV- infected infants was 235 g (95% confidence interval [CI] = 94 to 376 g) less than that of HIV-uninfected infants born to HIV-positive mothers (the reference group). After adjustment for gestational age, socioeconomic factors, maternal age, parity, hematocrit, and anthropomorphic measures, mean birth weight of HIV-infected infants was 154 g (95% CI = 38 to 271 g) lower than that of the reference group. When infants born to HIV-seronegative mothers were compared with the reference group, mean birth weights did not differ. Adjusted models resulted in estimates of mean head circumference 0.6 cm smaller (95% CI = 0.2 to 1.1 cm), ponderal index 0.14 lower (95% CI = 0.05 to 0.23), weight/head ratio 3.5 lower (95% CI = 0.5 to 6.4), and gestational age 0.5 weeks shorter (95% CI = 0.1 to 0.9 weeks) for HIV-infected infants than for the reference group. CONCLUSIONS: After adjustment for potential confounding variables, this study showed statistically significant differences in birth weight, gestational age, ponderal index, and weight/head ratio when HIV-infected infants were compared with noninfected infants born to HIV-positive mothers. HIV-1, mother-to-child transmission, Africa, intrauterine growth, birth weight, gestational age, ponderal index.
Assuntos
Síndrome da Imunodeficiência Adquirida/transmissão , Desenvolvimento Embrionário e Fetal , HIV-1 , Transmissão Vertical de Doenças Infecciosas , Complicações Infecciosas na Gravidez , Resultado da Gravidez , Síndrome da Imunodeficiência Adquirida/diagnóstico , Adolescente , Adulto , Antropometria , Peso ao Nascer , Relação CD4-CD8 , Estudos de Casos e Controles , Cefalometria , Estudos de Coortes , Intervalos de Confiança , Fatores de Confusão Epidemiológicos , Escolaridade , Feminino , Seguimentos , Idade Gestacional , Humanos , Recém-Nascido , Masculino , Programas de Rastreamento , Idade Materna , Bem-Estar Materno , Análise Multivariada , Paridade , Gravidez , Estudos Prospectivos , Distribuição Aleatória , Fatores de Risco , Ruanda/epidemiologia , Fumar/epidemiologiaRESUMO
A study of temporal trends in mammography screening and changes in stage of disease at diagnosis was conducted among Hispanic and non-Hispanic white female members of the Lovelace Health Plan, Flexcare Plan, and Lovelace Senior Plan/Senior Options (LHP), a managed care organization. Two-year screening rates for female members ages 50-74 years were calculated for 1989-1996. From 1989-1996, mammography screening rates for non-Hispanic white female members increased from 65.5 to 71.6%, although this was not a statistically significant increase. Screening rates for Hispanic female members also increased from 50.6 to 62.7%, but they were significantly lower than for non-Hispanic white women. All breast cancers occurring among LHP female members ages 40-74 years were also identified for this same time period. A logistic regression model adjusting for age, year of diagnosis, ethnicity, and duration of enrollment prior to diagnosis found that statistically significant predictors of more advanced stage of disease at diagnosis included young age, diagnosis after 1991 for non-Hispanic white women, and diagnosis prior to 1992 for Hispanic women. Longer duration of enrollment prior to diagnosis was predictive of lower stage of disease, but the odds ratio was not statistically significant. For the time period 1992-1996, Hispanic women with breast cancer were more than twice as likely to have advanced stage of breast cancer compared with non-Hispanic white women (odds ratio, 2.12).
Assuntos
Neoplasias da Mama/diagnóstico por imagem , Neoplasias da Mama/patologia , Hispânico ou Latino/estatística & dados numéricos , Mamografia , População Branca/estatística & dados numéricos , Idoso , Neoplasias da Mama/etnologia , Carcinoma in Situ/diagnóstico por imagem , Carcinoma in Situ/etnologia , Carcinoma in Situ/patologia , Feminino , Humanos , Programas de Assistência Gerenciada , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Análise de RegressãoRESUMO
BACKGROUND: Recommendations regarding therapeutic use of (131)I for patients with well-differentiated thyroid cancer remain controversial. Between 1969 and 1993, 1171 patients with papillary (including mixed) or follicular thyroid cancer were reported to the New Mexico Tumor Registry. Of these, 1075 cases (77.6% female, median age 41 years) were available for analysis of survival plots and previously recognized risk factors. Extent of operation was documented for 344 patients. METHODS: One hundred twenty-seven (37%) patients underwent postoperative (131)I ablation. Median follow-up was 99 months. A proportional hazards model was constructed using age, gender, stage, histology, and use of radioiodine. The same variables plus extent of operation were examined in the smaller group. RESULTS: Kaplan-Meier survival estimates at 12 years were 96.2% for patients younger than 45 years and 68.6% for those older than 45 years. Age, gender, and histology, but not stage, were important survival variables (P <.05). Adjusting for other risk factors, there was no apparent survival benefit associated with radioiodine following clinically appropriate thyroidectomy. Findings from the small group mirrored those of the large group. CONCLUSIONS: (131)I may not be as efficacious as previously believed for patients with well-differentiated thyroid cancer confined to the neck.
Assuntos
Adenocarcinoma Folicular/radioterapia , Carcinoma Papilar/radioterapia , Radioisótopos do Iodo/uso terapêutico , Neoplasias da Glândula Tireoide/radioterapia , Adenocarcinoma Folicular/mortalidade , Adenocarcinoma Folicular/cirurgia , Adolescente , Adulto , Idoso , Carcinoma Papilar/mortalidade , Carcinoma Papilar/cirurgia , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , New Mexico/epidemiologia , Prognóstico , Modelos de Riscos Proporcionais , Radioterapia Adjuvante , Estudos Retrospectivos , Programa de SEER , Análise de Sobrevida , Neoplasias da Glândula Tireoide/mortalidade , Neoplasias da Glândula Tireoide/patologia , Neoplasias da Glândula Tireoide/cirurgia , TireoidectomiaRESUMO
OBJECTIVES: This study (1) investigates the relationship of nonmalignant respiratory disease to underground uranium mining and to cigarette smoking in Native American, Hispanic, and non-Hispanic White miners in the Southwest and (2) evaluates the criteria for compensation of ethnic minorities. METHODS: Risk for mining-related lung disease was analyzed by stratified analysis, multiple linear regression, and logistic regression with data on 1359 miners. RESULTS: Uranium mining is more strongly associated with obstructive lung disease and radiographic pnuemoconiosis in Native Americans than in Hispanics and non-Hispanic Whites. Obstructive lung disease in Hispanic and non-Hispanic White miners is mostly related to cigarette smoking. Current compensation criteria excluded 24% of Native Americans who, by ethnic-specific standards, had restrictive lung disease and 4.8% who had obstructive lung disease. Native Americans have the highest prevalence of radiographic pneumoconiosis, but are less likely to meet spirometry criteria for compensation. CONCLUSIONS: Native American miners have more nonmalignant respiratory disease from underground uranium mining, and less disease from smoking, than the other groups, but are less likely to receive compensation for mining-related disease.
Assuntos
Hispânico ou Latino/estatística & dados numéricos , Indígenas Norte-Americanos/estatística & dados numéricos , Mineração/estatística & dados numéricos , Doenças Profissionais/etnologia , Doenças Respiratórias/etnologia , Fumar/efeitos adversos , Urânio , População Branca/estatística & dados numéricos , Indenização aos Trabalhadores/normas , Colorado/epidemiologia , Volume Expiratório Forçado , Humanos , Modelos Lineares , Modelos Logísticos , New Mexico/epidemiologia , Doenças Profissionais/etiologia , Doenças Profissionais/fisiopatologia , Prevalência , Doenças Respiratórias/etiologia , Doenças Respiratórias/fisiopatologia , Sudoeste dos Estados Unidos/epidemiologiaRESUMO
The route of breathing, oral or nasal, is a determinant of the doses of inhaled pollutants delivered to target sites in the upper and lower respiratory tracts. We measured partitioning of ventilation, using a divided oronasal mask during a submaximal exercise test, in 37 male and female subjects who ranged in age from 7 to 72 y. The following four patterns of breathing were evident during exercise: (1) nasal only (13.5%), nasal shifting to oronasal (40.5%), oronasal only (40.5%), and oral only (5.4%). Children (i.e., 7-16 y of age) displayed more variability than adults with respect to their patterns of ventilation with exercise. Young adults (i.e., 17-30 y of age) who initially breathed nasally with exercise switched to oral ventilation at a lower percentage of the previously measured maximum ventilation (10.8%) than older subjects (31.8%). The partitioning of ventilation between the nasal and oral routes follows complex patterns that cannot be predicted readily by the age, gender, or nasal airway resistance of the subject.
Assuntos
Envelhecimento/fisiologia , Respiração Bucal/fisiopatologia , Nariz/fisiologia , Respiração/fisiologia , Adolescente , Adulto , Idoso , Resistência das Vias Respiratórias , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Respiração com Pressão Positiva/instrumentação , Testes de Função Respiratória/métodos , Testes de Função Respiratória/estatística & dados numéricosRESUMO
We conducted a multicenter case-control study of clinically and histologically diagnosed idiopathic pulmonary fibrosis (IPF), a chronic diffuse interstitial lung disease of unknown cause. The study included 248 cases, and 491 control subjects identified through random-digit dialing, matched to cases in sex, age, and geographic region. Telephone interviews were conducted with both cases and controls to collect information on potential risk factors for IPF, including smoking and household, occupational, and environmental exposures. Pulmonary function tests, X-rays, computed tomographic (CT) scans of the chest, and lung biopsy reports were submitted by referring centers to support the diagnoses. An a priori hypothesis that smoking is associated with IPF was examined with conditional logistic regression analyses. More cases (72%) than control subjects (63%) had a history of ever smoking. The odds ratio (OR) for ever smoking was 1.6 (95% CI: 1.1 to 2.4). Risk was significantly elevated for former smokers (OR = 1.9; 95% CI: 1.3 to 2.9) and for smokers with 21 to 40 pack-yr (OR = 2.3; 95% CI: 1.3 to 3.8). A history of smoking is associated with an increased risk for the development of IPF. Although there was no clear exposure-response pattern with cumulative consumption of cigarettes, there was a trend for time since cessation of smoking, with the highest risk for those who had most recently quit.
Assuntos
Fibrose Pulmonar/etiologia , Fumar/efeitos adversos , Adulto , Idoso , Estudos de Casos e Controles , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Fatores de RiscoRESUMO
BACKGROUND: The personal health experiences of medical students may contribute in important but previously unacknowledged ways to their well-being and education. This pilot study surveyed medical students about their health care needs, practices, insurance status, and concerns about seeking care. METHOD: A questionnaire was developed and distributed to 151 students at the University of New Mexico School of Medicine in 1993-94. Participant privacy was protected. Responses were compiled and analyzed using logistic regression models and odds ratios. RESULTS: A total of 112 students responded. Most reported health care needs and half routinely received care at their training institution. One-third had informally requested prescriptions or diagnostic tests from medical school faculty and housestaff; one-fourth used such informal consultation as their "usual" method of obtaining care. Eighteen students were uninsured. The students reported that they had not sought care for several reasons, and many had experienced difficulty in obtaining care. The students indicated concern about confidentiality and about the dual role as both student and patient at the training institution. They believed that their academic standing would be jeopardized if they developed certain health problems. When asked about hypothetical scenarios, a majority preferred to avoid the dual role of medical-student-patient. When asked about scenarios in which medical student peers exhibited suicidal depression or severe drug abuse, the students overwhelmingly preferred not to notify the medical school administration. Significant differences in responses were found with respect to gender and training level. CONCLUSION: This pilot study examined the health care needs, practices (including the use of informal consultation), insurance status, and concerns of students at one medical school. The findings highlight the students' perceptions of illness and vulnerability during medical school training. Constructive implications for academic medicine are discussed regarding initiatives in the areas of policy, research, and the resources and structure of student health care services.
Assuntos
Acessibilidade aos Serviços de Saúde , Necessidades e Demandas de Serviços de Saúde , Aceitação pelo Paciente de Cuidados de Saúde , Estudantes de Medicina , Adulto , Atitude Frente a Saúde , Feminino , Humanos , Seguro Saúde , Masculino , Projetos Piloto , Estudantes de Medicina/psicologia , Inquéritos e QuestionáriosRESUMO
The study's objective was to survey what and how psychiatry residents want to learn about ethics during residency. A 4-page questionnaire developed for this study was sent to 305 residents at 10 adult psychiatry programs in the United States. One-hundred and eighty-one (59%) of those surveyed responded. Seventy-six percent reported facing an ethical dilemma in residency for which they felt unprepared. Forty-six percent reported having received no ethics training during residency. More than 50% of the respondents requested that "more" curricular attention be paid to 19 specific ethics topics and more than 40% for 25 topics. Preferences with respect to learning methods are presented. This survey may provide guidance in structuring the content and process of ethics education for psychiatry residents. These findings should stimulate the efforts of faculty to commit time and attention to this important curricular area.